Connect with us

NEWS

Another Nigerian herbal COVID-19 drug now undergoing clinical trial

Published

on

A HERBAL drug produced for management of COVID-19 by Afe Babalola University, Ado-Ekiti (ABUAD), Virucidine Liquid, is going through a proof of clinical trial.

  Chief Medical Director of ABUAD Multi-System Hospital, Ado-Ekiti, Dr Kolawole Ogundipe, disclosed this in a news conference..

  Explaining the drug which as “an immune booster and anti-oxidant for coronavirus and other viral infections, can also be used as an anti-inflammatory agent,” Ogundipe said the four-year-old medical facility is bridging the critical gap in health care investment in Nigeria.

  “The herbal drug produced by the Pharmacy Department of the hospital in conjunction with ABUAD Research Centre, had got NAFDAC’s nod and listing for production and sales. It is currently going through a proof of clinical trial for use in the management of COVID-19 by the Nigerian Institute for Medical Research. With the giant leaps being made by this hospital in terms of proficiency and quality medical services, Nigerians do not have reason to travel abroad for medicare. AMSH is working tirelessly to halt outward medical tourism, which is draining several billions of naira from Nigerians yearly, by acquiring the best equipment and an array of medical professionals that can handle any complicated situation. We appeal to our people, particularly the political class that they have no reason traveling abroad for medical services,” Ogundipe said.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published.

Advertisement
Advertisement
Advertisement

Top Posts

Advertisement

Trending